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In the past, occupational exposure of workers
to mixtures of soluble and insoluble nickel
compounds during specific nickel refinery
operations correlated with increased incidences
of nasal and respiratory cancer in workers
(1–6). The U.S. National Toxicology Program
(NTP) recently conducted rigorous animal
carcinogenicity studies with speciﬁc insoluble
and soluble nickel compounds to determine
whether they were carcinogenic. The NTP
studies showed that nickel subsulﬁde adminis-
tered by inhalation induced lung tumors in
F344 rats but not in B6C3F1 mice (7). The
NTP also showed that green (high tempera-
ture) NiO administered by inhalation caused
lung tumors in rats, but evidence for tumori-
genicity was equivocal in mice (8). Soluble
nickel sulfate administered by inhalation was
not carcinogenic to rats or mice (9).
Our laboratory (10) and the laboratory of
M. Costa (11–14) have studied whether solu-
ble and insoluble nickel compounds could
induce morphological and neoplastic transfor-
mation in cultured mammalian cells. Our lab-
oratory used a model in vitro cell culture
system derived by Reznikoff et al. from
embryos of C3H mice, designated C3H/
10T1/2 Cl 8 (10T1/2) (15). This sponta-
neously immortalized, hyperdiploid cell line
has a low saturation density, a low frequency
of spontaneous morphological transformation,
and a low frequency of spontaneous anchor-
age independence, and does not form tumors
in nude mice (15). We and others showed
that these cells undergo morphological trans-
formation when exposed to a broad range of
carcinogens, including polycyclic aromatic
hydrocarbons (16,17), aromatic amine
metabolites (17), radiation (18), aﬂatoxin B1
(19), and lead chromate [(20); reviewed in
(21,22)]. Many transformed cell lines derived
from foci induced by chemical carcinogens
and radiation in 10T1/2 cells grow in soft agar
and form tumors when injected into nude
mice [(16–20; reviewed in (21,22)].
Our laboratory showed that specific
insoluble carcinogenic nickel compounds,
including nickel subsulfide (10,23), crystal-
line nickel monosulfide (NiS) (10), black
(low-temperature, LT) NiO (23), and green
(high-temperature, HT) NiO (10,23), induce
morphological transformation in 10T1/2 cells
(Table 1) [reviewed in (24–26)]. We also
showed that transformed cell lines derived
from foci induced by crystalline NiS (10) and
by green (HT) NiO (calcined at a tempera-
ture above 1,100°C) (10, 27) and black (LT)
NiO (calcined at a temperature below
1,100°C) (27) have stable focus-forming and
anchorage-independent phenotypes. One
transformed cell line induced by green (HT)
NiO forms ﬁbrosarcomas when injected into
nude mice (10). We are studying whether
additional transformed cell lines induced by
black (LT) NiO and by green (HT) NiO are
tumorigenic (27).
Our ﬁndings that speciﬁc insoluble nickel
compounds induce morphological transforma-
tion in 10T/12 cells show that 10T1/2 cells
can be used as a model cell culture system to
study cellular and molecular mechanisms of
carcinogenesis induced by specific insoluble
nickel compounds. These studies are relevant
to understanding mechanisms by which nasal
and lung cancers are induced in nickel
refinery workers. Our laboratory has been
conducting such studies. We also showed that
concentrations of nickel subsulﬁde and green
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In the past, exposure of workers to mixtures of soluble and insoluble nickel compounds by
inhalation during nickel reﬁning correlated with increased incidences of lung and nasal cancers.
Insoluble nickel subsulﬁde and nickel oxide (NiO) are carcinogenic in animals by inhalation; sol-
uble nickel sulfate is not. Particles of insoluble nickel compounds were phagocytized by
C3H/10T1/2 mouse embryo cells and induced morphological transformation in these cells with
the following order of potency: NiO (black) > NiO (green) > nickel subsulﬁde. Foci induced by
black/green NiO and nickel monosulﬁde developed into anchorage-independent transformed cell
lines. Random arbitrarily primed-polymerase chain reaction mRNA differential display showed
that nine c-DNA fragments are differentially expressed between nontransformed and nickel com-
pound–transformed 10T1/2 cell lines in 6% of total mRNA; 130 genes would be differentially
expressed in 100% of the mRNA. Fragment R3-2 was a sequence in the mouse calnexin gene,
fragment R3-1 a portion of the Wdr1 gene, and fragment R2-4 a portion of the ect-2 proto-
oncogene. These three genes were overexpressed in transformed cell lines. Fragment R1-2 was
90% homologous to a fragment of the DRIP/TRAP-80 (vitamin D receptor interacting
protein/thyroid hormone receptor–activating protein 80) genes and was expressed in nontrans-
formed but not in nickel-transformed cell lines. Speciﬁc insoluble carcinogenic nickel compounds
are phagocytized into 10T1/2 cells and likely generate oxygen radicals, which would cause muta-
tions in protooncogenes, and chromosome breakage, and mutations in tumor suppressor genes,
inactivating them. These compounds also induce methylation of promoters of tumor suppressor
genes, inactivating them. This could lead to permanent overexpresssion of the ect-2, calnexin,
and Wdr1 genes and suppression of expression of the DRIP/TRAP-80 gene that we observed,
which likely contribute to induction and maintenance of transformed phenotypes. Key words:
clastogenesis, insoluble nickel compounds, morphological transformation, mRNA differential
display, phagocytosis. Environ Health Perspect 110(suppl 5):845–850 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-5/845-850landolph/abstract.html
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(HT) NiO that induce morphologic trans-
formation in 10T1/2 cells do not induce
mutation to ouabain resistance in these cells
(Table 1) [(10); reviewed in (24–26)], and
nickel subsulﬁde does not induce mutation to
ouabain resistance or to 6-thioguanine resis-
tance in cultured human diploid ﬁbroblastic
cells [(28); summarized in Table 1; reviewed in
(24–26)]. These assays measure restricted types
of base substitution mutations (ouabain resis-
tance and 6-thioguanine resistance), frameshift
mutations, and deletions (6-thioguanine resis-
tance) but do not detect large multigenic dele-
tions and mutations caused by oxygen radicals
efficiently. Therefore, the mechanisms by
which specific insoluble nickel compounds
induce morphological and neoplastic transfor-
mation are unique.
In this article we describe and review our
findings that specific insoluble nickel
compounds induce cytotoxicity, micronuclei,
chromosomal aberrations, and morphological
transformation in 10T1/2 cells. We next
describe and summarize our preliminary
results, using random arbitrarily primed
(RAP)-polymerase chain reaction (PCR)
mRNA differential display to analyze gene
expression in transformed 10T1/2 cell lines
induced by crystalline NiS and green (HT)
NiO and compare this to gene expression in
nontransformed 10T1/2 cells. Finally, we syn-
thesize our experimental ﬁndings to date into
an overall model that delineates the molecular
and cellular steps that occur during induction
of morphological and neoplastic transforma-
tion of 10T1/2 mouse embryo cells by speciﬁc
insoluble, carcinogenic nickel compounds.
Materials and Methods
Cells and cell culture. C3H/10T1/2 Cl 8
(10T1/2) mouse embryo cells were cultured in
Basal Eagles Medium containing 10% fetal
calf serum without antibiotics on Corning
ﬂasks and dishes (Corning Glass Co., Corning,
NY, USA) as described (10,15–17,21).
Samples of fetal calf serum obtained from sup-
pliers (Omega Scientific, Inc., Tarzana, CA,
USA; Gemini Bio-Products, Calabasas, CA,
USA) were screened to identify those that sup-
ported a plating efﬁciency greater than 30%, a
saturation density less than one million
cells/60-mm cell culture dish, and 10–20
foci/20 dishes when cells were treated with
1µ g/mL of the carcinogen, 3-methylcholan-
threne, or 3.75 µg/mL green (HT) NiO
[(10,17,20); reviewed in (21)].
Phagocytosis of particles of insoluble nickel
compounds. Phagocytic uptake of particles of
insoluble nickel compounds was quantitated
by our standard methods (10). Two hundred
cells were seeded per 60-mm dish, ﬁve dishes
per assay point, and treated 24 hr later with
25 µL of an acetone suspension containing the
insoluble nickel compound to be studied in
each 60-mm dish. Forty-eight hours later,
medium was removed, and cells were rinsed
with phosphate-buffered saline (PBS), fixed
with 70% ethanol, then stained with crystal
violet. Cells containing phagocytic vacuoles
with one or more particles of insoluble nickel
compounds were scored by light microscope
(10). To determine whether phagocytosed
particles were taken into lysosomes, cells were
seeded, treated 24 hr later with acetone sus-
pensions of insoluble nickel particles for
48 hr, stained in the living state with acridine
orange, then examined by fluorescence
microscopy (23,29–31). Cells containing par-
ticles of nickel compounds that colocalized
with the red ﬂuorescence of acridine orange in
lysosomes were scored as containing particles
taken up into lysosomes (23).
Cytotoxicity of insoluble nickel compounds.
Cytotoxicity caused by insoluble carcinogenic
nickel compounds was measured by our stan-
dard methods quantitating reduction in plat-
ing of treated cells (10). Cells were seeded,
then treated 24 hr later with suspensions of
insoluble nickel compounds in acetone for
48 hr. Ten days postseeding, or when colonies
became visible by microscope, medium was
removed from dishes, and cells were ﬁxed with
methanol, then stained with Giemsa. Colonies
containing 20 or more cells were counted by
dissecting microscope (10,17,20,21).
Chromosomal aberrations induced by
insoluble nickel compounds. Cells were seeded,
treated 24 hr later for 48 hr with suspensions
of nickel compounds in acetone, treated with
colcemid to induce metaphase arrest, swelled
in hypotonic potassium chloride solution, then
dropped onto slides. Slides were air dried,
stained with Giemsa, and examined under a
light microscope to determine the types and
frequencies of chromosomal aberrations
(23,32,33).
Induction of morphological transformation
by insoluble nickel compounds. Morphological
transformation was induced and quantitated
by our standard methods [(10,17,20);
reviewed in (21)]. Two thousand cells were
seeded into each of twenty 60-mm dishes for
each concentration of nickel compound
tested, then treated 24 hr later with 25 µL ace-
tone suspension of nickel compound in each
60-mm dish for 48 hr. Medium containing
nickel compounds was removed and replaced
with medium not containing nickel com-
pounds, replaced twice per week until cells
became confluent, then replaced once every
week. Six weeks postseeding of assays, cells
were rinsed with PBS, fixed with methanol,
then stained with Giemsa. Type II and type III
foci of morphologically transformed cells
were scored with a dissecting microscope
[(10,17,20); reviewed in (21)]. Transformed
cell lines were developed from foci induced by
green (HT) NiO and crystalline NiS and char-
acterized as described (10).
Analysis of mRNAs of nontransformed and
transformed 10T1/2 cell lines by RAP-PCR
mRNA differential display. mRNA was
extracted from nontransformed and trans-
formed cell lines by standard methods (34)
and copied into small complementary DNA
(cDNA) fragments (100–500 base pairs [bp])
by reverse transcription (35–37). These small
cDNA fragments were ampliﬁed by PCR, then
analyzed on DNA sequencing gels (35–37).
cDNA fragments present in nontransformed
10T1/2 cells but absent in one or more trans-
formed 10T1/2 cell lines and fragments absent
from nontransformed 10T1/2 cells but present
in one or more transformed cell lines were
eluted from gels, subcloned (35–37), and used
as probes in Northern gel analyses (34).
Subclones used as probes in Northern analysis
that yielded the same pattern of differential
gene expression seen in differential display gels
were sequenced by automatic DNA sequenc-
ing. Sequences of fragments were entered into
the BLAST database to determine homology
with fragments of known genes (38).
Results
Phagocytosis of particles of insoluble nickel
compounds by 10T1/2 cells and cytotoxicity
of these particles to 10T1/2 cells. How do
insoluble nickel compounds induce
cytotoxicity in 10T1/2 cells? We found that
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Table 1. Summary of the genotoxicity of speciﬁc insoluble nickel compounds.
Ability to induce:
Mutation Mutation  to
Mutation to ouabain  6-thioguanine
to ouabain resistance in resistance in Micronuclei Chromosomal Morphological
resistance in diploid human diploid human formulation in aberrations in transformation
Compound 10T1/2 cells ﬁbroblasts ﬁbroblasts 10T1/2 cells 10T1/2 cells in 10T1/2 cells
Nickel subsulﬁde – – – + + +
Green (HT) NiO – ND ND + + +
Black (LT) NiO ND ND + + +
Abbreviations: +, positive response, a dose-dependent and >2-fold increase; –, negative (no) response; ND, not
determined. Data on mutagenicity of nickel subsulfide and green (HT) NiO in 10T1/2 cells from Miura et al. (10); data on
mutagenicity of nickel subsulfide in diploid human fibroblasts from Biedermann and Landolph (28); data on morphologi-
cal transformation from Miura et al. (10) and Verma et al. (23); data on induction of chromosomal aberrations from
Verma et al. (23); data on micronuclei induction from Verma and Landolph (39). Some entries in this table are modified
and adapted from Landolph (24,25).Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 847
10T1/2 cells actively phagocytose particles
of certain insoluble nickel compounds
(10,23). After a 48-hr treatment of 10T1/2
cells with particles of insoluble nickel sub-
sulfide, cells exhibit one or more vacuoles
with particles of insoluble nickel compounds
(10,23). Phagocytosis of particles of insolu-
ble nickel subsulfide is dependent upon the
amount of particles added to cells and upon
the length of time cells are treated with par-
ticles (10,23). Phagocytosis of particles of
insoluble nickel subsulﬁde or crystalline NiS
deposits a large amount of ionic nickel into
cells (Figure 1) (12,23).
We next determined where inside cells the
insoluble nickel compounds were deposited.
In 10T1/2 cells treated with particles of nickel
subsulﬁde, then stained in the living state with
acridine orange, we observed the lysosomal
network outlined by the orange ﬂuorescence
of acridine orange in the acidic environment
of lysosomes by fluorescence microscopy.
Fixing the same acridine orange–stained cells
with 70% ethanol, staining them with crystal
violet, and examining them by light
microscopy demonstrated that particles of
nickel subsulﬁde in vacuoles co-localized with
the orange ﬂuorescence of acridine orange in
lysosomes (23). This indicated particles of
nickel subsulﬁde were localized in lysosomes
(23). In cells treated with black (LT) NiO or
green (HT) NiO, the cellular location of these
particles as visualized by light microscopy was
the same as that of the orange ﬂuorescence of
acridine orange in the lysosomes (23). This
indicated that particles of green and black
NiO were also phagocytized and localized in
lysosomes, although large phagocytic vacuoles
were not apparent (10,23).
Uptake of particles of insoluble nickel
compounds into cells generates intracellular
nickel divalent (+2) ions, which bind to many
proteins within cells, including proteins com-
plexed to DNA (Figure 1). This is the ﬁrst step
in induction of cytotoxicity, chromosomal
aberrations, and morphological transformation.
We showed that over concentration ranges at
which particles of insoluble nickel com-
pounds are phagocytosed, these particles
induced dose-dependent cytotoxicity in
10T1/2 cells (10,23). The order of cytotoxic-
ity we found for nickel compounds we stud-
ied was as follows: black (LT) NiO > green
(HT) NiO > nickel subsulfide > soluble
nickel sulfate (10,23).
Induction of chromosomal aberrations and
morphological transformation in 10T1/2 cells
by particles of insoluble nickel compounds. In
10T1/2 cells treated with particles of insoluble
nickel compounds, after uptake of particles of
insoluble nickel compounds by phagocytosis,
we also observed chromosomal aberrations.
Chromosomal aberrations induced in cells
treated with insoluble nickel compounds
included gaps, breaks, fragments, dicentrics,
and satellite associations (23). Induction of
chromosomal aberrations was dose dependent
for each insoluble nickel compound used to
treat 10T1/2 cells (23). The clastogenic
potency of nickel compounds was green (HT)
NiO > nickel subsulﬁde > black (LT) NiO >
nickel sulfate (23).
We also showed that nickel subsulfide
(10,23), green (HT) NiO (23), black (LT)
NiO (23), and crystalline NiS (10) induced
type II and type III foci of morphologically
transformed cells in 10T1/2 cells (Table 1).
The yield of type II + type III foci was dose
dependent with each insoluble nickel com-
pound studied (10,23). The efficiency with
which these compounds induced morphologi-
cal transformation was NiO (black) > NiO
(green) > nickel subsulﬁde (23). When foci of
transformed cells were cloned with glass
cloning rings and expanded into transformed
cell lines, the transformed cell lines stably
maintained an ability to form foci and to form
colonies in soft agar (10,27). One transformed
cell line induced by green (HT) NiO formed
progressively growing fibrosarcomas when
injected into nude mice (10). Additional trans-
formed cell lines derived from foci induced by
treating 10T1/2 cells with black (LT) and
green (HT) NiO are being tested for tumori-
genicity. Therefore, 10T1/2 cells provide a cell
culture system in which to study induction of
morphological and neoplastic transformation
of cells in vitro that can be used as a model for
studying carcinogenesis by specific insoluble
carcinogenic nickel compounds.
We found that nickel subsulﬁde and green
(HT) NiO induced chromosomal aberrations
(23), micronuclei (39), and morphological
transformation (10,23) in 10T1/2 cells but
did not induce mutation to ouabain resistance
in 10T1/2 cells (Table 1) (10). Similarly,
nickel subsulﬁde did not induce mutation to
6-thioguanine resistance and did not induce
mutation to ouabain resistance in cultured
diploid human ﬁbroblasts (28) (Table 1).
Molecular biology of deregulation 
of gene expression in carcinogenic nickel
compound–induced, transformed 10T1/2
cell lines. We next used the method of
RAP–PCR mRNA differential display
(35–37) to analyze gene expression in trans-
formed cell lines induced by green (HT)
NiO and crystalline NiS (35–37). When we
analyzed 6% of the total mRNA of nontrans-
formed and transformed cell lines by running
five differential display gels, we found that
nine genes were expressed differentially
between nontransformed 10T1/2 cells and
transformed cell lines induced by crystalline
NiS and green (HT) NiO (40). Expression
of some genes was decreased or extinguished,
and some genes were overexpressed or their
expression was activated in transformed
10T1/2 mouse embryo cell lines compared
to their expression in nontransformed
10T1/2 cells (40). Extrapolation to 100%
coverage of the mRNA indicated that approx-
imately 130 genes are differentially expressed
between nontransformed 10T1/2 cells and
nickel compound–induced, transformed cell
lines (40).
We isolated those 100–500 bp cDNA
fragments that were differentially expressed
from differential display gels, subcloned these
fragments, then conducted Northern (34) or
reverse Northern (40) blotting analysis with
these subcloned fragments and RNA extracted
from nontransformed and transformed
10T1/2 cells. We then selected those frag-
ments whose expression in Northern or
reverse Northern blot analysis reproduced the
differential expression of the original frag-
ments in the differential display gels. These
fragments were sequenced automatically, and
the sequences were entered into the BLAST
database. We identified a number of RNA
fragments that were overexpressed. One
cDNA fragment was a fragment of the mouse
calnexin gene (40,41), which maps to the q35
region of chromosome 5 of humans (42,43)
and encodes a molecular chaperone (44)
(Figure 2). A second cDNA fragment was a
fragment of the ect-2 gene (45), which maps
to mouse chromosome band 3B and to
3q26.1-q26.2 in humans (46,47) and encodes
a guanosine diphosphate (GDP)-guanosine
triphosphate (GTP) exchange factor for the
rho family of guanosine triphosphate (48–50).
A third cDNA fragment was a fragment of the
Wdr-1 gene (51), a novel stress-response gene
identiﬁed by the laboratory of M. Lomax (52)
that maps to human chromosome 4p (53).
One gene fragment whose expression is extin-
guished in transformed cell lines is a fragment
of the DRIP/TRAP-80 gene (vitamin D
receptor interacting protein/thyroid hormone
receptor–activating protein 80) (40), which
maps to chromosome 11 in humans (54). The
protein product of the DRIP/TRAP-80 gene
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Cellular uptake of insoluble nickel compounds
NiS NiS
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Cytoplasm Nucleus
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Cell transformation
Figure 1. Summary figure and schematic figure
detailing the ability of crystalline NiS and nickel
subsulfide to be phagocytosed into mammalian
cells, and the subsequent breakdown of the phago-
cytic vesicle, liberating Ni2+ ions into the cell,
where they subsequently bind to proteins in the
cell, including those proteins bound to DNA.serves as part of a complex that interacts with
the vitamin D–vitamin D receptor complex to
stimulate transcription (55,56) and with the
thyroid hormone receptor–thyroid hormone
complex to activate transcription (57).
Additional genes whose expression is extin-
guished in the transformed cell lines include
the insulin-like growth factor-1 receptor gene
(40) and two unknown genes (40).
Discussion
Uptake of specific insoluble carcinogenic
nickel compounds, genetic toxicology of these
compounds, and molecular mechanisms of
carcinogenesis induced by these compounds.
Particles of specific insoluble carcinogenic
nickel compounds, such as nickel subsulﬁde,
crystalline NiS, green (HT) NiO, and black
(LT) NiO, are taken into 10T1/2 cells and
other cell types by phagocytosis (10–12)
(Figure 1) and localize within lysosomes (23).
Over the concentration ranges at which parti-
cles of insoluble nickel compounds were
taken up into 10T1/2 cells, cytotoxicity
(10,23), chromosomal aberrations (23),
micronuclei (39), and morphological trans-
formation (10,23) also occurred (Table 1). A
plot of the slopes of the dose–response curves
for morphological transformation induced by
insoluble nickel compounds versus the per-
cent of cells phagocytizing particles of insolu-
ble nickel compounds was linear (23). Hence,
uptake and internalization of particles of
insoluble nickel compounds is an early and
key step in morphological transformation
induced by the specific insoluble nickel
compounds we studied (23).
We showed that nickel subsulfide and
NiO did not cause mutation to ouabain resis-
tance in 10T1/2 cells (10), and nickel subsul-
fide did not cause mutation to ouabain
resistance or mutation to 6-thioguanine resis-
tance in diploid human fibroblasts (28).
These two mutagenesis assays are not effective
at detecting the specific types of mutations
caused by oxygen radicals such as superoxide
and hydroxyl radicals. For instance, adri-
amycin, which generates superoxide radicals
[reviewed in (58)], does not elicit signiﬁcant
mutagenic responses in assays that detect
mutation to ouabain resistance or mutation
to 6-thioguanine resistance (59). We there-
fore propose alternative mechanisms other
than the type of mutations detected in assays
for ouabain resistance (speciﬁc base substitu-
tion mutations) or for 6-thioguanine resis-
tance (base substitution and frameshift
mutations and small deletions) to explain
mechanisms of carcinogenicity of these spe-
cific insoluble nickel compounds. We pro-
pose first that cellular uptake of particles of
insoluble nickel compounds is followed by
intracellular solubilization of Ni2+ ions and
their binding to cellular proteins, particularly
those bound to DNA (Figure 1). We then
propose that nickel ions bound to proteins
that are bound to DNA (Figure 1), such as
histones, react with intracellular hydrogen
peroxide (H2O2) (Figure 3). The H2O2
would be generated by the action of superox-
ide dismutase on intracellularly generated
superoxide (60,61). Ni2+ ions bound to pro-
teins complexed to DNA could react with
intracellular H2O2 in Fenton-like reactions
(60,61). This would generate reactive
hydroxyl radicals (Figure 3) [reviewed in
(60,61)] that would then immediately react
with DNA, leading to DNA damage, includ-
ing 8-hydroxydeoxyguanosine, and muta-
tions, which could induce cytotoxicity and
chromosomal aberrations (Figure 3).
Hydroxyl radicals, generated by interac-
tion of nickel ion–protein complexes proxi-
mate to DNA with H2O2 in Fenton-like
reactions (Figure 3), likely induce mutations
in protooncogenes, activating them into
oncogenes (Figure 4), and likely also induce
mutations in tumor suppressor genes, inacti-
vating them. Ni2+ ion–generated hydroxyl
radicals also likely inactivate tumor suppres-
sor genes by causing loss or breakage of the
chromosomes bearing these tumor suppressor
genes (Figure 4). Therefore, Ni2+ ion–gener-
ated hydroxyl radicals likely cause some of the
DNA damage observed in cells treated with
insoluble nickel compounds. This DNA
damage likely leads to cytotoxicity, micronu-
clei, chromosomal aberrations, and morpho-
logical transformation observed in cells
treated with insoluble nickel compounds
(Figures 3, 4) (10–14,23–28).
Deregulation of gene expression in nickel
compound–transformed cell lines and
implications for molecular mechanisms of
carcinogenicity of insoluble nickel compounds.
We now have some insight into the molecular
mechanisms of morphological transformation
induced by green (HT) NiO, black (LT)
NiO, crystalline NiS, and nickel subsulﬁde in
10T1/2 cells. Nickel ion–generated H2O2 and
hydroxyl radicals likely cause damage to
approximately eight speciﬁc genes (Figures 3,
4). These events likely cause differential
expression of approximately 130 genes
between the nickel compound–induced,
transformed 10T1/2 cell lines and nontrans-
formed 10T1/2 cells that we observed (40).
Four of these genes are likely protooncogenes.
Activation of these protooncogenes into onco-
genes then causes each one to stimulate signal
transduction pathways downstream of these
genes, such that each activated oncogene stim-
ulates expression of approximately 16 genes
(Figure 4). Four of these genes are probably
tumor suppressor-like genes. Ni2+ ion–gener-
ated hydroxyl radicals cause mutation or chro-
mosome breakage and inactivate these tumor
suppressor genes (Figures 3, 4). These tumor
suppressor–like genes may also become quies-
cent because of nickel ion–induced chromoso-
mal condensation, resulting in methylation of
the promoters of these genes (29). This results
in the transcriptional silencing of approxi-
mately 64 genes controlled by these tumor
suppressor–like genes. This model suggests
that approximately 130 genes (8 original pro-
tooncogenes and tumor suppressor genes × 16
genes whose expression they each stimulate
transcription of) would be differentially
expressed in transformed cell lines induced by
specific insoluble, carcinogenic nickel com-
pounds (Figure 4). We predict that this com-
bination of mutational activation of four
protooncogenes into oncogenes and muta-
tional inactivation, chromosomal breakage, or
methylation of, and silencing of, four tumor
suppressor–like genes, leads to deregulation of
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Possible mechanism of DNA damage caused by Ni2+
O2
– + O2
– + SOD H2O2
Ni2+
OH°
Fenton-like reaction:
Ni2+ + H2O2 Ni3+ + OH– + OH°
Single-strand DNA breaks
Altered DNA–protein binding
Chromosomal aberrations
Altered DNA methylation
●
●
●
●
Figure 3. Schematic illustration of the generation
of hydroxyl radicals in 10T1/2 cells by Ni2+ ion
bound to proteins (histones) that are bound to
DNA, and DNA damage that can be caused by
this site-specific generation of hydroxyl radicals
proximate to DNA.
Calnexin and cell transformation
Higher steady-
state levels of
calnexin mRNA
Increased levels
of
calnexin protein
Cytoplasm
Gene
amplication
Increased
transcription
rate
Decreased
decay rate
Gene
mutation
Calnexin gene
Figure 2. Schematic indicating that the mRNA and
protein products of the calnexin gene are
expressed at higher steady-state levels in trans-
formed 10T1/2 cell lines induced by treatment of
10T1/2 cells with crystalline NiS and green (HT)
NiO (38,39). Possible ways that could have caused
the production of higher steady-state levels of cal-
nexin mRNA and protein are suggested.the ﬁnely tuned gene expression of the normal
cell. This stepwise deregulation of gene
expression degrades the biological behavior of
the nontransformed, well-regulated, contact-
inhibited 10T1/2 cell, which cooperates with
its neighboring cells, into that of a trans-
formed, biologically autonomous cell. This is
a stochastic process. For each tumor cell, a dif-
ferent set of genes may be altered, and they
may be altered in a different order in time
among tumor cells bearing the same changes
in the same genes.
Which specific genes are targets for
damage caused by nickel ion–generated,
activated oxygen metabolites? How have
these genes become damaged, and which of
these damaged genes contribute to induction
and maintenance of the transformed state?
Our preliminary data indicate that one of
these genes is the ect-2 gene (45), which
encodes a GDP–GTP exchange factor for
the rho family of genes (48–50) and is
located on human chromosome 3q26.1-
q26.2 (46) and on mouse chromosome band
3B (47). This protooncogene can be
activated in other systems to an oncogene by
mutation (48–50). This gene is expressed at
higher steady-state levels in transformed cell
lines induced by crystalline NiS and green
nickel (HT) oxide (45). We are working to
determine whether and how this gene has
become activated in transformed cell lines
induced by these two insoluble nickel com-
pounds (45). By precedent with other
tumors bearing an activated ect-2 oncogene,
there may be mutations in the 5´ region of
this gene, thus activating it.
A second gene we found expressed at
higher steady-state levels in nickel
compound–induced transformed cells is cal-
nexin (Figure 2) (40,41). The calnexin gene
has been localized to human chromosome
5q35 (43), and calnexin protein is a molecular
chaperone (44). We are in the process of test-
ing three hypotheses: a) that this gene is
transcriptionally activated by other proto-
oncogenes; b) that it acts as a protooncogene
itself when mutated; or c) that overexpression
of calnexin protein leads it to sequester and
hence inhibit activity of proteins of tumor
suppressor genes (Figures 2, 4).
A third gene overexpressed in transformed
cell lines induced by NiS and green (HT)
NiO is the Wdr1 gene (51). The laboratory of
M. Lomax first identified Wdr1 as a novel
gene overexpressed in the ears of chickens
exposed to acoustic shock (51). Wdr1 gene
maps to human chromosome 4p (53). We do
not know whether this gene functions as a
protooncogene or whether its protein
functions as a gene in a signal transduction
pathway that can be stimulated by prior
expression of an oncogene. Studies to answer
these questions are in progress (51).
An intriguing gene that we found
expressed in nontransformed 10T1/2 cells
but not in nickel compound–induced, trans-
formed 10T1/2 cell lines (40) encodes
DRIP/TRAP-80 (51–57). The DRIP/
TRAP-80 gene maps to human chromosome
11 (54). DRIP/TRAP-80 protein binds to
the vitamin D–vitamin D receptor complex,
conferring on this complex the ability to
mediate transcriptional activation of specific
genes by vitamin D (55,56). DRIP/TRAP-80
protein also helps activate the thyroid
hormone–thyroid hormone receptor complex
so it can mediate transcriptional activity con-
ferred by thyroid hormone (56). We hypoth-
esize that Ni2+ ions generate hydroxyl radicals
(Figure 3), which cause inactivation of
expression of the DRIP/TRAP-80 gene by
causing inactivating mutations in this gene or
by inducing breakage of the chromosome
bearing this gene. Nickel ions themselves may
bind to histones and cause chromosomal con-
densation (29), which results in methylation
(29) of the promoter of the DRIP/TRAP-80
gene (Figures 3, 4). Loss of DRIP/TRAP-80
protein would abolish transcriptional activity
of the vitamin D–vitamin D receptor com-
plex, which is involved in tumor suppression
(54,55). Studies are in progress in our labora-
tory to critically test these hypotheses of how
the DRIP/TRAP-80 gene is inactivated.
The overall mechanistic model we propose
to indicate how specific insoluble carcino-
genic nickel compounds induce morphologi-
cal and neoplastic transformation is as
follows: a)T hese nickel compounds generate
intracellular Ni2+ ions that induce oxygen
radicals, which induce activating mutations in
specific protooncogenes or protooncogene-
controlled genes (ect-2, Wdr-1, and calnexin
genes) and inactivating mutations or dele-
tions in tumor suppressor or suppressor-like
genes (DRIP/TRAP-80). b) Intracellular Ni2+
ions also cause chromosomal condensation
and methylation of promoters of tumor sup-
pressor genes, inhibiting expression of these
genes and genes downstream that they tran-
scriptionally control (29). These multiple
events result in enhanced expression of
approximately 64 genes whose expression is
driven by the protein products of the ect-2,
Wdr1, and calnexin genes and likely another
protooncogene; loss of expression or signifi-
cantly decreased expression of approximately
64 genes whose expression is driven by the
DRIP/TRAP-80 protein and the DRIP/TRAP
complex; and three other protein products
of as yet unidentified genes (Figure 4).
Accumulation of these events would severely
degrade the growth control apparatus of the
cell and convert the nontransformed cell into
a transformed cell (Figure 4). Studies to criti-
cally test these hypotheses and this overall
model are in progress in our laboratory.
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Figure 4. Schematic model for induction of morphological transformation in 10T1/2 cells treated with speciﬁc
insoluble carcinogenic nickel compounds, such as nickel subsulﬁde, green (HT) NiO, black (LT) NiO, and
crystalline NiS. These nickel compounds induce morphological transformation in 10T1/2 cells. They likely do
so by generating hydroxyl radicals (Figure 3), which then cause mutation in and activation of protooncogenes
into oncogenes. This causes induction of higher steady-state levels of calnexin mRNA, Wdr-1 mRNA, and
ect-2 mRNA. These hydroxyl radicals also cause mutations in tumor suppressor genes and break chromo-
somes bearing tumor suppressor genes, leading to loss of and/or inactivation of, tumor suppressor genes.
Intracellular nickel ions may also cause methylation of the promoters of tumor suppressor genes, leading to
inhibition of their expression. This leads to inhibition of the synthesis of the mRNA encoded by the
DRIP/TRAP-80 gene and by two novel unknown genes. Each activated oncogene can further activate expres-
sion of 20 other genes downstream of it and in the same signal transduction pathway. Inactivation of each
tumor suppressor gene can also result in the loss of expression of approximately 20 other genes for which
the protein product of this tumor suppressor gene acts as a transcriptional factor. These events in total can
cumulatively result in the degradation of a nontransformed cell into a transformed cell.REFERENCES AND NOTES
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